Open AccessImpact of Diffuse Large B-Cell Lymphoma on Mammography and Bone Density Testing in Women
Author(s) -
Rahul Garg,
Usha Sambamoorthi,
Xi Tan,
Soumit Basu,
Treah Haggerty,
Kimberly A. Kelly
Publication year - 2021
Publication title -
the journal of primary prevention/the journal of primary prevention
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.511
H-Index - 53
eISSN - 1573-6547
pISSN - 0278-095X
DOI - 10.1007/s10935-021-00621-8
Subject(s) - medicine , breast cancer , mammography , oncology , diffuse large b cell lymphoma , cancer , lymphoma
Women with diffuse large B-cell lymphoma (DLBCL) are at an increased risk of mortality from breast cancer and osteoporosis. However, the impact of DLBCL on rates of mammography and bone density testing (BDT) is unknown. We compared female DLBCL and non-cancer patients utilizing the Surveillance, Epidemiology, and End Results-Medicare dataset to analyze the predictors of mammography and BDT. Guided by the Social Ecological Model (SEM), we used multivariable logistic regressions with inverse probability treatment weighting to examine the association of intrapersonal, interpersonal, healthcare system, and community factors with mammography and BDT. The rates of mammography (59.8%) and BDT (18.5%) in women with DLBCL were similar to those without cancer (60.2% and 19.6%, respectively). After adjusting for the SEM factors, DLBCL patients were less likely to get mammography and BDT than non-cancer patients. The treatments of radiotherapy and stem cell transplant were not associated with either mammography or BDT. DLBCL diagnosis was associated with lower rates of mammography and BDT rates among women with DLBCL, as compared to non-cancer patients. To reduce the morbidity and mortality from breast cancer and fractures in women with DLBCL, providers should increase their recommendations for mammography in those receiving radiotherapy and BDT in stem cell transplant patients.